Page last updated: 2024-12-07

2,3-bis(3'-hydroxybenzyl)butyrolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

2,3-bis(3'-hydroxybenzyl)butyrolactone: lignan isolated from urine of humans & other mammals; RN given refers to cpd without isomeric designation; structure given in second source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114739
CHEMBL ID2391150
CHEBI ID81555
SCHEMBL ID11306724
MeSH IDM0094083

Synonyms (26)

Synonym
enterolactone
3,4-bis((3-hydroxyphenyl)methyl)dihydro-2-(3h)-furanone
2(3h)-furanone, dihydro-3,4-bis((3-hydroxyphenyl)methyl)-, (3r,4r)-rel-
hpmf
2,3-bis(3'-hydroxybenzyl)butyrolactone
enterolactone, ~95% (hplc)
C18165
(+/-)-enterolactone
CHEMBL2391150
(+)-enterolactone
chebi:81555 ,
SCHEMBL11306724
unii-x01e7e1d6h
ccris 3048
x01e7e1d6h ,
compound 180/442
(3r,4r)-rel-dihydro-3,4-bis((3-hydroxyphenyl)methyl)-2(3h)-furanone
trans-(+/-)-2,3-bis(3'-hydroxybenzyl)-.gamma.-butyrolactone
enterolactone [mi]
hbbl
HMS3648C19
(+/-)-enterolactone, analytical standard
dihydro-3,4-bis((3-hydroxyphenyl)methyl)-2(3h)-furanone
trans-2,3-bis(3-hydroxybenzyl) butyrolactone
SR-01000946199-1
sr-01000946199

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These changes, which have also been reported for other (flaxseed) lignans, were not considered to represent adverse effects."( A thirteen week dietary toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats.
Korte, H; Lina, B; Nyman, L; Unkila, M, 2005
)
0.33

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic parameters and urinary excretion of enterodiol and enterolactone were evaluated after consumption of their purified plant precursor, secoisolariciresinol diglucoside (SDG)."( Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside.
Arts, IC; Hollman, PC; Kuijsten, A; Vree, TB, 2005
)
0.33
"A single-blind, parallel, pharmacokinetic and dose-comparison study was conducted on 22 postmenopausal females not receiving hormone replacement therapy."( Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study.
Brown, DJ; Hardy, M; Tan, MO; Udani, JK, 2013
)
0.39
" These data suggest a similar pharmacokinetic profile between the enriched and polymer form of SDG, providing support for the use of SDG polymer as a more economical precursor for SECO, ED, and EL in applications of chronic disease management."( Oral Pharmacokinetics of Enriched Secoisolariciresinol Diglucoside and Its Polymer in Rats.
Alcorn, J; Guo, Y; Mustafa, R; Purdy, SK; Reaney, MJT; Shen, J; Tse, TJ; Yang, X, 2021
)
0.62

Compound-Compound Interactions

ExcerptReferenceRelevance
"This study determined the effect of the mammalian lignans enterolactone (ENL) and enterodiol (END) alone and in combination with the isoflavone genistein (GEN) on the growth of MCF-7 tumors in ovariectomized nude mice."( Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice.
Chen, JM; Power, KA; Saarinen, NM; Thompson, LU, 2006
)
0.33
" The lignans do not exert adverse effects on any tissue, however, when combined with GEN, they exert an adverse effect on the uterus."( Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model.
Chen, JM; Power, KA; Saarinen, NM; Thompson, LU; Ward, WE, 2006
)
0.33

Bioavailability

ExcerptReferenceRelevance
" Further studies will also be needed to determine the bioavailability and absorption rate of lignans."( Determinants of serum enterolactone concentration.
Adlercreutz, H; Kilkkinen, A; Pietinen, P; Stumpf, K; Tapanainen, H; Valsta, LM, 2001
)
0.31
" In a third study with six pigs, we quantified the bioavailability of the plant lignans that can be converted to enterolactone (lariciresinol, matairesinol, pinoresinol, secoisolariciresinol and syringaresinol) and the concentration in the peripheral blood."( Rye bread in the diet of pigs enhances the formation of enterolactone and increases its levels in plasma, urine and feces.
Adlercreutz, H; Bach Knudsen, KE; Heinonen, SM; Kjaer, AK; Nurmi, T; Serena, A; Tetens, I, 2003
)
0.32
" Information concerning their dietary sources and bioavailability is scarce."( Intake of lignans is associated with serum enterolactone concentration in Finnish men and women.
Adlercreutz, H; Kilkkinen, A; Pietinen, P; Stumpf, K; Valsta, LM; Virtamo, J, 2003
)
0.32
" More research is warranted to determine the bioavailability of lignins in the human diet."( Dietary lignins are precursors of mammalian lignans in rats.
Adlercreutz, H; Begum, AN; Fukushima, K; Heinonen, SM; Lapierre, C; Mila, I; Nagano, K; Nicolle, C; Rémésy, C; Scalbert, A, 2004
)
0.32
" For a proper evaluation of potential health effects of enterolignans, information on their bioavailability is essential."( The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed.
Arts, IC; Hollman, PC; Kuijsten, A; van't Veer, P, 2005
)
0.33
" These results indicate that SDG hydrolysis is not a common feature in Bifidobacterium genus, but selected probiotic strains can be combined to β-glucoside-based prebiotics to enhance the release of SECO, thus improving its bioavailability for absorption by colonic mucosa and/or the biotransformation to ED and EL by other intestinal microorganisms."( Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside.
Amaretti, A; Leonardi, A; Raimondi, S; Roncaglia, L; Rossi, M, 2011
)
0.37
" ENL is estrogenic with no effect on the E-screen test and is a natural Selected Estrogen Receptor Modulator (SERM) with health interests that have to be checked in clinical studies with bioavailability assessment."( Design and validation of a novel immunological test for enterolactone.
Baguenard, L; Bennetau, B; Bennetau-Pelissero, C; Lamothe, V; Pinot, E; Schmitter, JM; Shinkaruk, S, 2014
)
0.4
" Our objective was to determine the bioavailability and pharmacokinetics of SDG in purified flaxseed extracts under dose-ranging and steady-state conditions, and to examine whether differences in secoisolariciresinol-diglycoside purity influence bioavailability."( Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans.
Brown, NM; Heubi, JE; Jha, P; Setchell, KD; Wolfe, B; Zimmer-Nechemias, L, 2014
)
0.4
" The purpose of this study was to evaluate the bioavailability of a proprietary 7-HMR product (HMRlignan, Linnea SA, Locarno, Switzerland) through measurement of lignan metabolites and metabolic precursors."( Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study.
Brown, DJ; Hardy, M; Tan, MO; Udani, JK, 2013
)
0.39
"Consumption of flaxseed lignans is associated with various health benefits; however, little is known about the bioavailability of purified lignans in flaxseed."( Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats.
Alcorn, J; Krol, ES; Muir, AD; Mukker, JK; Singh, RS, 2015
)
0.42
"The ATP-binding cassette transporter G2/breast cancer resistance protein (ABCG2/BCRP) is an efflux protein involved in the bioavailability and milk secretion of endogenous and exogenous compounds, actively affecting milk composition."( Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid.
Álvarez, AI; Espín, JC; García-Villalba, R; González-Lobato, L; Merino, G; Miguel, V; Otero, JA; Prieto, JG, 2016
)
0.43
" The extent of SDG release from the polymer and subsequent bioavailability of SDG metabolites are unknown."( Oral Pharmacokinetics of Enriched Secoisolariciresinol Diglucoside and Its Polymer in Rats.
Alcorn, J; Guo, Y; Mustafa, R; Purdy, SK; Reaney, MJT; Shen, J; Tse, TJ; Yang, X, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
"To analyse the lignan content of phloem powder enriched rye bread and to study the dose-response relationship of the effect of dietary plant lignans derived from phloem on intestinal production of enterolactone by measuring enterolactone concentration in serum."( Phloem fortification in rye bread elevates serum enterolactone level.
Adlercreutz, H; Mursu, J; Nurmi, T; Rissanen, TH; Salonen, JT; Salonen, R; Vanharanta, M; Voutilainen, S, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID752382Inhibition of rat intestinal soluble alpha-glucosidase using 4-nitrophenyl-alpha-D-glucopyranoside as substrate assessed as enzyme activity after 30 mins by spectrophotometry relative to control2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Flaxseed (Linum usitatissimum L.) extract as well as (+)-secoisolariciresinol diglucoside and its mammalian derivatives are potent inhibitors of α-amylase activity.
AID752381Inhibition of immobilized rat intestinal alpha-glucosidase using 4-nitrophenyl-alpha-D-glucopyranoside as substrate assessed as enzyme activity after 30 mins by spectrophotometry relative to control2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Flaxseed (Linum usitatissimum L.) extract as well as (+)-secoisolariciresinol diglucoside and its mammalian derivatives are potent inhibitors of α-amylase activity.
AID752379Inhibition of pig pancreas soluble alpha-amylase using 4-nitrophenyl-alpha-D-maltopentaoside as substrate after 30 mins by spectrophotometry2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Flaxseed (Linum usitatissimum L.) extract as well as (+)-secoisolariciresinol diglucoside and its mammalian derivatives are potent inhibitors of α-amylase activity.
AID752380Inhibition of pig pancreas soluble alpha-amylase using 4-nitrophenyl-alpha-D-maltopentaoside as substrate assessed as enzyme activity after 30 mins by spectrophotometry relative to control2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Flaxseed (Linum usitatissimum L.) extract as well as (+)-secoisolariciresinol diglucoside and its mammalian derivatives are potent inhibitors of α-amylase activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (307)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (5.86)18.7374
1990's27 (8.79)18.2507
2000's128 (41.69)29.6817
2010's118 (38.44)24.3611
2020's16 (5.21)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials32 (10.03%)5.53%
Reviews17 (5.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational2 (0.63%)0.25%
Other268 (84.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]